ANP32E expression in pancreatic cancer is associated with impaired gemcitabine efficacy and poor patient prognosis

• DOI: 10.1016/j.mcp.2025.102030
• Publication Date: 2025-04-28T23:15:28Z
• Authors: Xiaohong Liu; Yelin Zhao; Li Zhang; Junting Wang; Liaoxin Luo; Shihui Zhang; Qin Zhu; Yuchen Shi; Chenyu Yuan; Qifeng Xiao; Mengran Xiong; Yuanyuan Duan; Hebing Chen; Hongjuan Yao; Lin Cai; Jianwei Zhang; Guangxi Li; Liang Li